Phase II Study, Evaluation of Safety and Efficacy of IdeS in Chronic Kidney Disease

Update Il y a 4 ans
Reference: NCT02224820

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

IdeS is an immunoglobulin g (IgG) cleaving enzyme. It will given to patients with donor specific antibodies to reduce the antibody load and thus enable kidney transplantation. IdeS antibody reducing efficacy and its safety will be studied.


Inclusion criteria

  • chronic kidney disease

Links